Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QRFPR | Q96P65 | 7/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.39 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.37 |
| ▸ | NPY4R | P50391 | 8/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.37 |
| ▸ | NPY1R | P25929 | 6/20 | 0.37 |
| ▸ | NPY2R | P49146 | 4/20 | 0.37 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590376 | 1.00 | QRFPR (0.42) | QRFPRPTGS1GSTK1GLO1NPY4R | |
| SCHEMBL30997463 | 0.99 | QRFPR (0.41) | QRFPRPTGS1GSTK1GLO1NPY4R | |
| SCHEMBL29591850 | 0.96 | QRFPR (0.39) | QRFPRPTGS1GSTK1GLO1NPY4R | |
| SCHEMBL29630453 | 0.95 | PTGS1 (0.39) | QRFPRPTGS1GSTK1GLO1NPY4R | |
| SCHEMBL29354257 | 0.94 | PTGS1 (0.41) | QRFPRPTGS1GSTK1GLO1NPY4R | |
| SCHEMBL30373025 | 0.93 | QRFPR (0.41) | QRFPRPTGS1GSTK1GLO1NPY4R | |
| SCHEMBL30372279 | 0.93 | QRFPR (0.41) | QRFPRPTGS1GSTK1GLO1NPY4R | |
| SCHEMBL31480014 | 0.92 | QRFPR (0.49) | QRFPRNPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL29590856 | 0.92 | QRFPR (0.49) | QRFPRNPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL21961850 | 0.92 | ITGB3 (0.40) | QRFPRPTGS1GSTK1GLO1NPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |